24 Porte du Grand
93 articles with MEDICREA
Medicrea Announces $30 Million Senior Secured Notes Issue and a Warrants Issue wholly subscribed by Perceptive Advisors
The Medicrea Group today announced the closing of a $30 million senior secured notes issue by Medicrea and wholly subscribed by Perceptive Advisors, a leading multi-strategy healthcare investment firm.
This Press Release includes hyperlinks. Click the blue words to access extra content including videos and abstracts.
The Medicrea Group announced today that the company will host one-on-one investor meetings during the 9th Annual Craig-Hallum Alpha Select Conference at the Sheraton New York Times Square Hotel on Thursday, November 15, 2018.
Third quarter sales: +14% (at constant exchange rate).
Medicrea Announces NASS 2018 Presence And Highlights a Recently Published Study Validating Its Predictive Modelling Approach for AIS Patients
The Medicrea Group announced today that the Company is attending the NASS 2018 meeting taking place in Los Angeles, California, from September 26th to 28th, where UNiD™ LAB biomedical engineers will showcase the most recent developments of the Company’s UNiD™ ASI technology.
Published its unaudited results for the first half of 2018, as approved by the Board of Directors on September 12, 2018.
Trades under symbols MRNTY and MRNTF
The Medicrea® Group announced that the Company has signed a joint-venture agreement with the Spine division of National Surgical Pty Ltd. to introduce the Group’s innovative products and patient-specific technologies in Australia and New Zealand.
MEDICREA INTERNATIONAL announces a capital increase of €3,083,777 with 4 U.S. institutional investors.
Continued growth momentum over first half of 2018
The Medicrea® Group announced that it has obtained the first and only 510(k) clearance from the U.S. Food & Drug Administration (FDA) to market patient-specific spinal cages through the extension of its UNiD™ technology to select from its IB3D™ range of 3D-printed titanium interbody devices.
The Medicrea® Group (Euronext Growth Paris: FR0004178572 - ALMED), pioneering the convergence of healthcare IT and next-generation, outcome-centered spinal device design and manufacturing with UNiD ASI™ (Adaptive Spine Intelligence) technology, announced today that the Company has signed a joint-venture agreement with Motion Medical
Medicrea Reports Directors’ Dealings Disclosure and Announces Transactions On Securities Of The Company
In accordance with Article 19 of Regulation (EU) No 596/2014 of April 16th, 2014, the Company has declared to the AMF the acquisition of 60,000 shares on February 13th, 2018 by its Chairman and Chief Executive Officer, Denys Sournac.
MEDICREA, pioneering the convergence of healthcare IT and next-generation, outcome-centered device design and manufacturing with UNiD ASI technology, announces transactions on securities of the Company by its Chairman and Chief Executive Officer.
AdapTEK allows a surgeon to create a range of interbody devices to their individual specifications that are then produced by Medicrea with complete in-house additive manufacturing capabilities and total control of the internal process without any of the limitations associated with subcontracting ...
The case has been assigned to the Honorable Analisa Torres, District Judge.
Medicrea Unveils New U.S. Business Development Model With Hiring of Joseph Walland As Executive Vice President of Sales and Richard Washburn as Executive Vice President UNiD™ ASI
The Medicrea Group announced today that the Company has hired Joseph Walland as Executive Vice President of U.S. Sales, and Richard Washburn as Executive Vice President UNiD™ ASI, to support its new business development model in the United States, effective October 23, 2017.
MEDICREA announced today that the Company will launch their UNiD HUB software at the 32nd Annual Meeting of the North American Spine Society (NASS), held October 25-28, 2017 in Orlando, Florida.
MEDICREA Showcases UNiD ASI Technology At Eurospine 2017 With The European Launch Of Its Proprietary UNiD HUB Software